Month: February 2019

Aachen. CRPS/Sudeck’s disease was conducted by the pharmaceutical manufacturer Grünenthal, Aachen, to conduct a clinical study on the active ingredient neridronate. Neridronic acid) launched an aminobisphosphate. In various clinics in Germany, sufferers can take part in this clinical trial. The studies will be conducted at sites in the US, Canada, Germany, France, the UK, Spain, …

Clinical trial on neridronate in Germany Read More »

A position paper on the treatment of CRPS in Europe was published in the European Journal of Pain in January. Well-known medical practitioners from Great Britain, Germany, Switzerland, Belgium, the Netherlands, France, Denmark and Poland as well as from Irsael and Australia have together put together the current methods and best practices to raise standards …

Position paper on the treatment of CRPS in Europe/Standards Read More »